The present invention relates to antibodies directed against TrkA receptor and their uses including humanized anti TrkA antibodies. More specifically the present invention relates to humanized anti TrkA antibodies with enhanced inhibitory properties comprising a heavy chain variable region a light chain variable region a human light chain constant region and a variant human IgG4 heavy chain constant region which exhibit altered exchange properties.